Muzaffer SANCI, Orhan TEMEL, Mustafa BAĞCI, Selçuk ERKILINÇ, Tuğba KARADENİZ, Mehmet GÖKÇÜ, Ulaş SOLMAZ

YÜKSEK RİSKLİ VE DÜŞÜK RİSKLİ ENDOMETRİUM KANSERLERİ HASTALARDA İLERİ YAŞ KÖTÜ PROGNOSTİK BİR FAKTÖR MÜDÜR?

Amaç: Yüksek riskli ve düşük riskli endometrium kanserinde ileri yaşın sağkalım üzerine etkisini araştırmak Metod: 1995-2015 yılları arasında düşük riskli 759, yüksek riskli 139 endometrium kanseri hastası çalışmaya dahil edildi. Demografik veriler, cerrahi tedavi verileri retrospektif olarak değerlendirildi. Yaşın sağkalım üzerine etkisinin araştırılması için Univariate ve multivariate regresyon analizi yapıldı. Bulgular: Düşük riskli ve yaşlı hastalarda genç hastalarla karşılaştırıldığında dış myometrial invazyon, radyoterapi, lefovasküler invazyon anlamlı olarak daha fazlaydı. Yüksek riskli yaşlı hastlarada sadece radyoterapi oranı yüksek bulundu. Yüksek riskli düşük riskli hastalarda ileri yaş total sağkalım için bağımsız bir risk faktörü olarak bulundu Sonuç: Hem yüksek riskli hem de düşük riskli endometrium kanserli hastalarda ileri yaş olumsuz prognostik bir faktör olarak bulunmuştur.

Is Advanced Age a Poor Prognostic Factor In High Risk and Low Risk Endometrial Cancer Patients?

Objective: To evaluate the effect of advanced age on high risk and low endometrial cancerpatients.Methods: A total of 759 patients with type I endometrial cancer and 139 patients with type IIendometrial cancer between January 1995 to December 2015 were included to the study. Highrisk and low risk patients were devided into two groups according to age. Demographic data,surgical treatment, adjuvant treatment and survival characteristics were compared betweenage groups in high risk and low risk patients. To detect the independent hazard of the variableson survival univariate and multivariate Cox regression analysis was performed.Results: Outer ½ myometrial invasion, adjuvant radiotherapy, LVSI, tumor diameter weresignificantly higher in advanced age groups in low risk patients. Admission of adjuvantradiotherapy was the only parameter that differed between older and younger age groups inhigh risk patients. Both disease free survival and overall survival were higher in younger lowrisk patients. Overall survival was longer in high risk and younger age patients, but disesasefree survival was similar. Multivariate Cox-regression analysis revealed that advanced age wasa significant independent hazard for overall survival both in high risk and low risk endometrialcancer patients (HR:1.94, 95% CI:1,0-3,4).Conclusion: Our study suggested that advanced age was a poor prognostic factor both for lowrisk and high risk endometrial cancer patients.

PDF

___

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer 2015;136:E359-E86.
2. Daniilidou K, Frangou-Plemenou M, Grammatikakis J, Grigoriou O, Vitoratos N, Kondi-Pafiti A. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study. J BUON 2013;18:195-201.
3. Jeannotte L, Moore MJ. The state of aging and health in America 2007. Merck Company Foundation; 2007.
4. Balducci L, Ershler WB. Cancer and ageing: a nexus at several levels. Nature Reviews Cancer 2005;5:655-62.
5. Tarver T. Cancer Facts & Figures 2012. American Cancer Society (ACS) Atlanta, GA: American Cancer Society, 2012. 66 p., pdf. Available from. Journal of Consumer Health on the Internet 2012;16:366-7.
6. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. The Lancet 2000;355:1404-11.
7. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecologic oncology 2004;92:744-51.
8. Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatinbased combined chemotherapy in patients with intermediate-and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic oncology 2008;108:226-33.
9. Wright JD, Lewin SN, Medel NIB, Sun X, Burke WM, Deutsch I, et al. Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome. Gynecologic oncology 2011;122:69-74.
10. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-7.
11. Mahdi H, Jernigan AM, Aljebori Q, Lockhart D, Moslemi-Kebria M. The impact of obesity on the 30-day morbidity and mortality after surgery for endometrial cancer. Journal of minimally invasive gynecology 2015;22:94-102.
12. Gayar OH, Robbins JR, Parikh K, Lu M, Buekers T, Munkarah A, et al. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome. Gynecologic oncology 2011;123:71-5.
13. Bourgin C, Saidani M, Poupon C, Cauchois A, Foucher F, Leveque J, et al. Endometrial cancer in elderly women: Which disease, which surgical management? A systematic review of the literature. European Journal of Surgical Oncology (EJSO) 2016;42:166-75.
14. Bourgin C, Saidani M, Poupon C, Cauchois A, Foucher F, Leveque J, et al. Endometrial cancer in elderly women: Which disease, which surgical management? A systematic review of the literature. European Journal of Surgical Oncology (EJSO) 2015.
15. Park JY, Nam J-H, Kim Y-T, Kim Y-M, Kim J-H, Kim D-Y, et al. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients. Virchows Archiv 2013;462:289-96.
16. Lachance J, Everett E, Greer B, Mandel L, Swisher E, Tamimi H, et al. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecologic oncology 2006;101:470-5.
17. De Marzi P, Ottolina J, Mangili G, Rabaiotti E, Ferrari D, Viganò R, et al. Surgical treatment of elderly patients with endometrial cancer (≥ 65years). Journal of geriatric oncology 2013;4:368-73.
18. Rauh-Hain JA, Pepin KJ, Meyer LA, Clemmer JT, Lu KH, Rice LW, et al. Management for elderly women with advanced-stage, highgrade endometrial cancer. Obstetrics & Gynecology 2015;126:1198- 206.
19. AlHilli MM, Bakkum-Gamez JN, Mariani A, Weaver AL, McGree ME, Keeney GL, et al. Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival. Gynecologic oncology 2015;138:133-40.
20. Solmaz U, Mat E, Ekin A, Gezer C, Biler A, Peker N, et al. Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas. Int J Surg 2016;32:71-7.